Template:DrugProjectFormSinglePage: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 172: | Line 172: | ||
{{#if: {{{useInPregnancyFDA|}}} | | {{#if: {{{useInPregnancyFDA|}}} | | ||
{{{useInPregnancyFDA}}} | | {{{useInPregnancyFDA}}} | | ||
There is no FDA guidance on usage of {{ | There is no FDA guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
}} | }} | ||
| Line 179: | Line 179: | ||
{{#if: {{{useInPregnancyAUS|}}} | | {{#if: {{{useInPregnancyAUS|}}} | | ||
{{{useInPregnancyAUS}}} | | {{{useInPregnancyAUS}}} | | ||
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{ | There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant. | ||
}} | }} | ||
| Line 186: | Line 186: | ||
{{#if: {{{useInLaborDelivery|}}} | | {{#if: {{{useInLaborDelivery|}}} | | ||
{{{useInLaborDelivery}}} | | {{{useInLaborDelivery}}} | | ||
There is no FDA guidance on use of {{ | There is no FDA guidance on use of {{PAGENAME}} during labor and delivery. | ||
}} | }} | ||
| Line 193: | Line 193: | ||
{{#if: {{{useInNursing|}}} | | {{#if: {{{useInNursing|}}} | | ||
{{{useInNursing}}} | | {{{useInNursing}}} | | ||
There is no FDA guidance on the use of {{ | There is no FDA guidance on the use of {{PAGENAME}} in women who are nursing. | ||
}} | }} | ||
| Line 200: | Line 200: | ||
{{#if: {{{useInPed|}}} | | {{#if: {{{useInPed|}}} | | ||
{{{useInPed}}} | | {{{useInPed}}} | | ||
There is no FDA guidance on the use of {{ | There is no FDA guidance on the use of {{PAGENAME}} in pediatric settings. | ||
}} | }} | ||
| Line 207: | Line 207: | ||
{{#if: {{{useInGeri|}}} | | {{#if: {{{useInGeri|}}} | | ||
{{{useInGeri}}} | | {{{useInGeri}}} | | ||
There is no FDA guidance on the use of {{ | There is no FDA guidance on the use of {{PAGENAME}} in geriatric settings. | ||
}} | }} | ||
| Line 214: | Line 214: | ||
{{#if: {{{useInGender|}}} | | {{#if: {{{useInGender|}}} | | ||
{{{useInGender}}} | | {{{useInGender}}} | | ||
There is no FDA guidance on the use of {{ | There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations. | ||
}} | }} | ||
| Line 221: | Line 221: | ||
{{#if: {{{useInRace|}}} | | {{#if: {{{useInRace|}}} | | ||
{{{useInRace}}} | | {{{useInRace}}} | | ||
There is no FDA guidance on the use of { | There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations. | ||
}} | }} | ||
| Line 228: | Line 228: | ||
{{#if: {{{useInRenalImpair|}}} | | {{#if: {{{useInRenalImpair|}}} | | ||
{{{useInRenalImpair}}} | | {{{useInRenalImpair}}} | | ||
There is no FDA guidance on the use of {{ | There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment. | ||
}} | }} | ||
| Line 235: | Line 235: | ||
{{#if: {{{useInHepaticImpair|}}} | | {{#if: {{{useInHepaticImpair|}}} | | ||
{{{useInHepaticImpair}}} | | {{{useInHepaticImpair}}} | | ||
There is no FDA guidance on the use of {{ | There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment. | ||
}} | }} | ||
| Line 242: | Line 242: | ||
{{#if: {{{useInReproPotential|}}} | | {{#if: {{{useInReproPotential|}}} | | ||
{{{useInReproPotential}}} | | {{{useInReproPotential}}} | | ||
There is no FDA guidance on the use of {{ | There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males. | ||
}} | }} | ||
| Line 249: | Line 249: | ||
{{#if: {{{useInImmunocomp|}}} | | {{#if: {{{useInImmunocomp|}}} | | ||
{{{useInImmunocomp}}} | | {{{useInImmunocomp}}} | | ||
There is no FDA guidance one the use of {{ | There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised. | ||
}} | }} | ||
| Line 336: | Line 336: | ||
==Look-Alike Drug Names== | ==Look-Alike Drug Names== | ||
{{{lookAlike}}} | {{{field|lookAlike|input type=textarea|size=35}}} | ||
}} | }} | ||
Revision as of 20:58, 21 March 2014
This is the "Drug Project Form" template. It should be called in the following format:
{{DrugProjectForm
|authorTag=
|genericName=
|drugClass=
|indication=
|commonAdverseReactions=
|isPill=
|pillImprint=
|dosageValue=
|dosageUnit=
|dosageFreeText=
|pillSize=
|pillShape=
|pillColor=
|pillScoring=
|pillImage=|hasBlackBoxWarning=
|blackBoxWarningTitle=
|blackBoxWarningBody=
|fdaLIADAdult=
|offLabelAdultGuideSupport=
|offLabelAdultNoGuideSupport=
|fdaLIADPed=
|offLabelPedGuideSupport=
|offLabelPedNoGuideSupport=
|contraindications=
|warnings=
|adverseReactions=
|clinicalTrials=
|postmarketing=
|drugInteractions=
|useInPregnancyFDA=
|useInPregnancyAUS=
|useInLaborDelivery=
|useInNursing=
|useInPed=
|useInGeri=
|useInGender=
|useInRace=
|useInRenalImpair=
|useInHepaticImpair=
|useInReproPotential=
|useInImmunocomp=
|administration=
|monitoring=
|IVCompat=
|overdose=
|drugBox=
|mechAction=
|structure=
|PD=
|PK=
|nonClinToxic=
|clinicalStudies=
|howSupplied=
|NDC=
|storage=
|manBy=
|distBy=
|drugImages=
|packLabel=
|fdaPatientInfo=
|nlmPatientInfo=
|alcohol=
|lookAlike=
|drugShortage=
|price=
}}
Edit the page to see the template text.